UK markets closed
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • FTSE 250

    20,338.96
    +93.53 (+0.46%)
     
  • AIM

    933.20
    +4.84 (+0.52%)
     
  • GBP/EUR

    1.1820
    +0.0002 (+0.02%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.52%)
     
  • BTC-GBP

    20,183.37
    +218.54 (+1.09%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • DOW

    33,761.05
    +424.38 (+1.27%)
     
  • CRUDE OIL

    91.88
    -2.46 (-2.61%)
     
  • GOLD FUTURES

    1,818.90
    +11.70 (+0.65%)
     
  • NIKKEI 225

    28,546.98
    +727.65 (+2.62%)
     
  • HANG SENG

    20,175.62
    +93.19 (+0.46%)
     
  • DAX

    13,795.85
    +101.34 (+0.74%)
     
  • CAC 40

    6,553.86
    +9.19 (+0.14%)
     

The Sun Pharmaceutical Industries share price - here is what analysts think

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Trading recommendations from company analysts can offer a glimpse of what the experts think the future holds. Their 'buy', 'hold' and 'sell' ratings reflect their views about the likely future performance of the stocks they cover - and how the share prices will move as a result.

For investors, these kinds of 'smart money' signals can be a useful consideration when it comes to deciding whether to buy or sell a stock...

Take Sun Pharmaceutical Industries (NSI:SUNPHARMA) as an example. Shares in the company have risen by 1.23% over the past month and they are currently trading at ₹857.7. But what do the analysts that cover the company think?

Based on the broker 'consensus', there could be reasons to believe that the positive recent trend will continue. In terms of trading recommendations, Sun Pharmaceutical Industries currently has:

  • 19 Buy recommendations

  • 2 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally upbeat about the outlook.

At its current price of ₹857.7, shares in Sun Pharmaceutical Industries are trading at a discount of -11.3% to its 52 week high price. The 1-year performance of the shares has been 28.6%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sun Pharmaceutical Industries it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Sun Pharmaceutical Industries that you can find out about here.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting